EPISODE · Jul 8, 2026 · 17 MIN
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
from BioSpace · host BioSpace
A surprising deal from Vertex Pharmaceuticals adds to Big Pharma’s acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked companies. Plus, FDA decisions slow only slightly as the hunt for a permanent leader drags on.
Embed this episode
NOW PLAYING
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
0:00
17:04
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of BioSpace?
This episode is 17 minutes long.
When was this BioSpace episode published?
This episode was published on July 8, 2026.
Can I download this BioSpace episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!